ReviewTherapeutics and clinical risk management2018

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook.

Dharmesh Gopalakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.